"HIV-2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker.
MeSH Number(s)
B04.820.650.589.650.350.410
B04.909.777.731.589.650.350.410
Concept/Terms
HIV-2- HIV-2
- HTLV-IV
- Immunodeficiency Virus Type 2, Human
- HIV-II
- Human T Lymphotropic Virus Type IV
- Human T-Lymphotropic Virus Type IV
- LAV-2
- Human immunodeficiency virus 2
- Human Immunodeficiency Virus Type 2
Below are MeSH descriptors whose meaning is more general than "HIV-2".
Below are MeSH descriptors whose meaning is more specific than "HIV-2".
This graph shows the total number of publications written about "HIV-2" by people in Harvard Catalyst Profiles by year, and whether "HIV-2" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 2 | 3 |
| 1994 | 4 | 1 | 5 |
| 1995 | 3 | 0 | 3 |
| 1996 | 3 | 1 | 4 |
| 1997 | 2 | 1 | 3 |
| 1998 | 6 | 1 | 7 |
| 1999 | 4 | 1 | 5 |
| 2000 | 6 | 0 | 6 |
| 2001 | 2 | 2 | 4 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 0 | 2 |
| 2005 | 2 | 0 | 2 |
| 2006 | 4 | 0 | 4 |
| 2007 | 6 | 0 | 6 |
| 2008 | 1 | 2 | 3 |
| 2009 | 2 | 2 | 4 |
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 3 | 0 | 3 |
| 2014 | 2 | 1 | 3 |
| 2015 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
Below are the most recent publications written about "HIV-2" by people in Profiles.
-
Implementation of an HIV RNA Qualitative PCR Assay in an HIV Diagnostic Algorithm: A Single-Institution Experience. Am J Clin Pathol. 2023 07 05; 160(1):11-17.
-
Novel assays to investigate the mechanisms of latent infection with HIV-2. PLoS One. 2022; 17(4):e0267402.
-
Association of HIV infection and antiretroviral therapy with the occurrence of an unfavorable TB treatment outcome in a rural district hospital in Eastern Cape, South Africa: A retrospective cohort study. PLoS One. 2022; 17(4):e0266082.
-
Development of a novel molecular assay based on conventional PCR liquid hybridization and ELISA (NAT-ELISA) for the detection of HIV, HCV, and HBV in blood donors. Indian J Med Microbiol. 2022 Jan-Mar; 40(1):122-126.
-
Case 24-2021: A 63-Year-Old Woman with Fever, Sore Throat, and Confusion. N Engl J Med. 2021 Aug 12; 385(7):641-648.
-
APOBEC3F Constitutes a Barrier to Successful Cross-Species Transmission of Simian Immunodeficiency Virus SIVsmm to Humans. J Virol. 2021 08 10; 95(17):e0080821.
-
Case 27-2020: A 53-Year-Old Woman with Headache and Gait Imbalance. N Engl J Med. 2020 Aug 27; 383(9):859-866.
-
Slow Receptor Binding of the Noncytopathic HIV-2UC1 Envs Is Balanced by Long-Lived Activation State and Efficient Fusion Activity. Cell Rep. 2020 06 09; 31(10):107749.
-
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections. Cell Host Microbe. 2019 07 10; 26(1):73-85.e4.
-
eCD4-Ig Limits HIV-1 Escape More Effectively than CD4-Ig or a Broadly Neutralizing Antibody. J Virol. 2019 07 15; 93(14).